Surotin Indications/Uses

Prevention of cardiovascular events: Rosuvastatin is used as an adjunct to non drug therapies in patients without clinical evidence of coronary heart disease (CHD) who have an increased risk of atherosclerotic cardiovascular disease based on age (men 50 years of age or older, women 60 years of age or older), high-sensitivity C-reactive protein (hsCRP) concentrations of 2 mg/L or greater, and at least on additional cardiovascular disease risk factor (e.g., hypertension, low HDL-cholesterol concentrations, smoking, family history of premature CHD).
Rosuvastatin is used to reduce total mortality and the risk of major cardiovascular events (cardiovascular death, stroke, myocardial infarction (MI), unstable angina, or undergoing arterial revascularization procedures).
Rosuvastatin is used to reduce progression of coronary atherosclerosis as adjunct to dietary therapy.
Dyslipidemias: Rosuvastatin is used as an adjunct to dietary therapy for the management of primary hyperlipidemia or mixed dyslipidemia, hypertriglyceridemia, primary dysbetalipoproteinemia and homozygous familial hypercholesterolemia.
Rosuvastatin is used as an adjunct to diet to reduce total cholesterol, LDL-C and apolipoprotein B (apo B) levels in patients with heterozygous familial hypercholesterolemia who are 6-17 years of age.